Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Energy Industry News Summit Midstream finalises $155m acquisition of Tall Oak Midstream Summit Midstream Corporation has completed its $155 million acquisition of Tall Oak Midstream Operating, LLC, marking a significant… byPallavi MadhirajuDecember 3, 2024